New Delhi, Oct 6: Glenmark Pharmaceuticals on Thursday said it has launched Thiazolidinedione Lobeglitazone in the country for the treatment of type 2 diabetes in adults. The Mumbai-based drug firm has launched the medication under the brand name LOBG and is priced at around Rs 10 per tablet. Indians have a high prevalence of insulin resistance and that makes LOBG an appealing treatment option in managing uncontrolled Type 2 diabetes among insulin-resistant diabetic patients, Glenmark Pharmaceuticals said in a statement. […]
NEW DELHI, Sept 23: Glenmark Pharmaceuticals on Friday announced approval by Health Canada for its nasal spray Ryaltris used in symptomatic treatment of moderate to severe seasonal allergic rhinitis and associated ocular symptoms. Health Canada granted approval to partner Bausch Health Companies Inc and Glenmark Specialty SA, a subsidiary of the company, for Ryaltris (olopatadine hydrochloride and mometasone furoate nasal spray), Glenmark Pharmaceuticals said in a statement. “This Health Canada approval will allow Bausch Health to soon make Ryaltris available […]
Get latest articles and stories on Latest News at LatestLY. Glenmark Pharmaceuticals on Wednesday reported a 31 per cent decline in its consolidated net profit at Rs 211 crore for the first quarter ended June on account of sales dip in domestic and US markets. Latest News | Glenmark Q1 Net Profit Declines 31 Pc to Rs 211 Crore.
Purulia recorded 30 mm rainfall in 24 hours till 8.30 am on Thursday as other parts of Gangetic West Bengal largely remained dry, , Asthama, glenmark pharmaceuticals
Consolidated revenues of the drug firm, however, rose to Rs 3,019 crore in the quarter under review as compared to Rs 2,860 crore in the year-ago period, recording an increase of 6 per cent year-on-year.